Anogenital lichen simplex chronicus (LSC) poses a therapeutic challenge as conventional treatment with topical steroids often yields unsatisfactory itch relief, and is limited by the risk of steroid atrophy. Tacrolimus is a calcineurin inhibitor that is effective in treating a wide range of chronic inflammatory dermatoses with an excellent safety profile. To the best of our knowledge, there are no prior published studies on the treatment of scrotal LSC. Our aim was to evaluate the efficacy of topical 0.1% tacrolimus ointment in the treatment of scrotal LSC.
- scrotal lichen simplex chronicus,
- observational study
Available at: http://works.bepress.com/andysltan/16/